We are a consortium funded by the European Commission, tasked with three objectives:
Creating a roadmap addressing the steps needed for the introduction of in silico clinical trials.
Establishing a partnership between the biomedical industry and European research organisations, with the aim of developing the technology, methods, protocols and standards required for in silico clinical trials to become a reality.
. Identifying technologies, determining early examples of in silico clinical trails.